Goldman Sachs BDC declares a $0.32 per share dividend, matching prior payouts, with a forward yield of 14.08%. Goldman Sachs BDC announced a $0.32 per share quarterly dividend, consistent with its previous distribution. The forward yield stands at 14.08%, reflecting the co
AMPH projects ongoing remediation expenses while reaffirming mid-to-high single-digit sales growth for 2026. Amphastar Pharmaceuticals expects to incur $2M to $3M in quarterly costs to address IMS remediation efforts. The company reported Q2 2026 revenue of approximately $
The insurer maintains its quarterly dividend at $0.50 per share, yielding 2.5% forward, with payment scheduled for September 30. American International Group declared a $0.50 per share quarterly dividend, unchanged from its previous payout. The dividend offers a forward yi
The company reported Q2 2026 revenue of $2.5 million as CMS proposes raising TULSA procedure payments to $15,494. Profound Medical Corp. maintained its 2026 revenue outlook of approximately $25 million following a CMS proposal to increase OPPS payments by 14.9% to $15,494
The laser manufacturer cites $17M in delayed shipments due to China-related supply chain disruptions impacting quarterly revenue. nLIGHT projected Q3 2026 revenue between $63M and $73M, reflecting a $17M shift in product shipments tied to China-related supply delays. The c
The dry bulk shipping firm projects strong cash flow over the next year driven by elevated freight rate expectations. Star Bulk Carriers expects to generate $4.1 per share in free cash flow over the next 12 months, based on a forward freight agreement curve of $22,000 per
The offshore drilling firm reports Q2 2026 adjusted EBITDA margin of 32%, exceeding guidance amid planned Valaris deal closure in Q4. Transocean reported a 32% adjusted EBITDA margin for Q2 2026, surpassing internal revenue and cost projections. The company attributed the
The medical tech firm raised its full-year revenue guidance and set a new gross margin target of 58%-61% for 2026. Senseonics increased its 2026 global net revenue guidance to a range of $62 million to $66 million, up from $60 million to $64 million. The adjustment reflect
VATE reports Q2 2026 revenue of $421.6 million and adjusted EBITDA of $46.3 million amid strategic equity agreement. Innovate Corp. announced a deal with CONX involving up to $75 million in equity while retaining the option to increase its broadcasting stake to 40%. The ag
Company reports Q2 revenue of $548 million and raises full-year earnings outlook amid improved profitability metrics. ICU Medical raised its 2026 adjusted earnings per share outlook to a range of $8.60 to $9.00, citing stronger-than-expected gross margins of 41.5%. The com
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.